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differentiated effector memory T (TEM) 
cells play a pivotal role in the pathogenesis 
of autoimmunity (4). Wulff et al. described 
that the characteristic potassium channel 
phenotype of TEM cells in multiple sclero-
sis (MS) is Kv1.3high IKCa1low, contrast-
ing naïve, and central memory T (TCM) 
cells, which exhibit a Kv1.3low IKCa1high 
channel phenotype (1). Therefore the thera-
peutic relevance of specific Kv1.3 channel 
inhibitors is of outstanding interest, as 
they may offer the possibility for selective 
modulation of pathogenic TEM cells, while 
naïve and TCM cells (needed for physiologi-
cal immune responses) would escape the 
inhibition through upregulation of IKCa1 
channel expression. Beeton et al. demon-
strated that the symptoms of experimental 
autoimmune encephalitis, a murine model 
of MS, significantly improved after treat-
ment with selective Kv1.3 inhibitors (5).
Although results from animal models 
are promising, limited data is available on 
the effects of potassium channel inhibition 
on T cell function in humans. Furthermore, 
besides naïve and memory T cells, altera-
tions in the activation pattern of effec-
tor (CD4+ helper and CD8+ cytotoxic) T 
lymphocytes have not been described upon 
Kv1.3 and IKCa1 inhibition. Although these 
cells might have a less-specific role in the 
maintenance of autoreactivity compared 
to TEM cells, their inhibition have impor-
tant consequences on the overall immune 
response. Therefore, over the recent years, 
we have investigated calcium influx charac-
teristics in effector T cell subsets in a num-
ber of autoimmune disorders.
We isolated peripheral blood mononu-
clear cells from MS, rheumatoid arthri-
tis (RA) and type 1 diabetes mellitus 
(T1DM) patients and applied a novel flow 
 cytometry-based approach for the detection 
of calcium influx (7–10). Until the recent 
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Currently available immunotherapies have 
improved the treatment of autoimmune 
diseases; however, these therapies are 
known to have considerable side-effects, 
such as increasing the susceptibility to 
infections. Therefore, there is an unmet 
need for novel immunosuppressive strat-
egies with different mechanisms of action 
and higher specificity for disease-causing 
autoreactive T lymphocytes from existing 
immunomodulators.
The increase of the cytoplasmic calcium 
concentration from intra- and extracellular 
sources (i.e., the endoplasmic reticulum and 
store-operated calcium entry through the 
plasma membrane) is the cornerstone of 
T lymphocyte activation and functional-
ity. In the course of lymphocyte activation, 
potassium channels maintain the driving 
force for sustained calcium influx from the 
extracellular milieu as they grant the efflux 
of potassium from the cytoplasm, thus 
conserving an electrochemical potential 
gradient between the intra- and extracel-
lular spaces. There are two major types of 
potassium channels in T cells: the voltage-
gated Kv1.3 and the calcium-activated 
IKCa1 channels. The relation between the 
calcium currents through calcium release-
activated calcium (CRAC) channels and the 
efflux of potassium makes the proliferation 
and activation of lymphocytes sensitive to 
pharmacological modulation of Kv1.3 and 
IKCa1 channels, and provides an oppor-
tunity for targeted intervention. Specific 
inhibition of these channels results in a 
diminished calcium influx in lymphocytes 
and a lower level of lymphocyte activation.
Previous data suggest that selective mod-
ulation of lymphocyte activation through 
specific inhibition of potassium channels 
may be a possible therapeutic approach 
for the treatment of autoimmune disease 
(1–6). Beeton et al. showed that terminally 
past, single-cell techniques were used for the 
investigation of calcium influx during lym-
phocyte activation. There has been no high-
throughput method available to study the 
kinetics of lymphocyte activation in more 
subsets at the same time. Single-cell tech-
niques are restricted by not being capable 
of characterizing this process in complex 
cellular systems, thus ignoring the interac-
tion between the different lymphocyte sub-
sets that may modulate the course of their 
activation. Therefore, over the recent years 
we have developed a novel algorithm that 
allows simultaneous monitoring of calcium 
influx in several lymphocyte subsets. Our 
software (FacsKin) fits functions to median 
values of the data of interest and calculates 
relevant parameters describing each func-
tion. By selecting the best fitting function, 
this approach provides an opportunity for 
the mathematical analysis and statistical 
comparison of kinetic flow cytometry meas-
urements of distinct samples (more details 
available at www.facskin.com). Our findings 
indicate important differences in calcium 
influx kinetics in the studied autoimmune 
disorders compared to healthy controls.
Multiple ScleroSiS
Multiple sclerosis is an autoimmune dis-
ease affecting the central nervous system 
(CNS). The autoimmune reaction primar-
ily destroys the myelin sheath covering the 
nerve cells. T lymphocytes play a key role in 
the pathogenesis of MS. They regulate the 
ongoing inflammatory process of the CNS 
which leads to the damage of the myelin 
sheath and axons. However, only a small 
part of T lymphocytes are myelin-specific 
autoreactive cells. Besides the  demyelinating 
action of these cells of the CNS, the activa-
tion of peripheral lymphocytes also con-
tributes to the pathogenesis and disease 
progression (11). In our investigations we 
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of Kv1.3 channel inhibitors would not have 
an exclusive effect on cells responsible for the 
autoimmune response in T1DM, but may 
have an impact on the activation character-
istics of immune cells in general (8).
SuMMary
Based on our results, a number of dominant 
features were identified that were present in 
the investigated autoimmune diseases. First, 
the time when the peak of calcium influx 
was reached decreased in autoimmune 
patients compared to healthy individuals, 
indicating that these cells are in a state of 
sustained reactivity due to the ongoing 
autoimmune reaction.
Earlier studies were limited to the inves-
tigation of potassium channels in naive and 
memory lymphocytes. We have extended 
these findings to significant effector T 
lymphocyte subsets, and found a different 
pattern of sensitivity to the inhibition of 
lymphocyte potassium channels in Th1 
cells of autoimmune patients compared to 
healthy individuals. In healthy controls the 
inhibition of the IKCa1 channel decreased 
calcium influx in Th2 and CD4 cells to a 
lower extent than in Th1 and CD8 cells. 
On the contrary, the inhibition of Kv1.3 
channels resulted in a larger decrease of 
calcium entry in Th2 and CD4 than in 
Th1 and CD8 cells. In the investigated 
autoimmune patients a greater decrease 
of calcium influx upon the inhibition of 
the Kv1.3 channel than that of the IKCa1 
channel was observed in Th1 cells. This 
finding is of special interest, since Th1 cells 
are regarded as key players in the mediation 
of pro-inflammatory responses.
However, the selectivity of the investi-
gated inhibitors was limited in our experi-
ments, as they did not only affect a single 
subset, as previously suggested. Although 
in earlier observations the inhibition of 
Kv1.3 channels specifically blocked the 
function of TEM cells, our investigations 
extending to significant effector T lym-
phocyte subsets demonstrated that the 
inhibitory effect is present not only in 
disease-associated CD8 and Th1 cells, but 
also in the anti-inflammatory Th2 subset. 
The induced decrease in their function 
could lead to unwanted side-effects and 
in a setback of therapy in vivo.
Therefore, further studies, including the 
analysis of functional consequences (such 
as cytokine production or proliferation) of 
These cells  regulate the inflammatory 
process  resulting in the destruction of the 
articular cartilage and also play a role in 
extra-articular damage. We investigated 
T lymphocyte calcium influx kinetics fol-
lowing activation in peripheral blood of 
recently diagnosed RA patients compared 
to healthy individuals. Our results indi-
cate that margatoxin (MGTX), a specific 
blocker of the Kv1.3 channel acts differen-
tially on calcium influx kinetics in major 
peripheral blood effector lymphocyte sub-
sets of RA patients. The immunomodula-
tory effect of Kv1.3 channel inhibition is 
predominantly seen in cytotoxic (CD8) T 
cells in RA. However, this effect does not 
seem to be as specific as reported before by 
Beeton and colleagues in case of TEM cells 
(2), since anti-inflammatory Th2 cells are 
also affected to a noteworthy extent. This 
subset has an important role in counterbal-
ancing the ongoing inflammatory process, 
and therefore its inhibition is not useful 
in the treatment of RA. A reason for lim-
ited specificity of Kv1.3 inhibition in the 
peripheral lymphocytes might be the dif-
ferential distribution of disease-associated 
autoreactive T cells in RA patients on local 
and systemic levels. In the synovial fluid 
(locally), autoreactive TEM cells, express-
ing high numbers of Kv1.3 channels are 
abundantly present. However, this Kv1.3 
pattern was not detected in peripheral 
blood T cells, because autoreactive TEM 
cells are infrequent in the circulation. 
Peripheral blood T cells were predomi-
nantly found to be naive and TCM cells (2).
type 1 DiabeteS MellituS
Our results indicate that the sensitivity of 
T1DM lymphocytes to the inhibition of 
Kv1.3 channels is increased compared to 
healthy individuals. It has been hypothesized 
that beneficial effects of Kv1.3 channel inhi-
bition by MGTX are due to the dominance 
of Kv1.3 channels on activated TEM cells 
(1, 2). It was also presumed that MGTX 
would inhibit the activation of CD8 lym-
phocytes responsible for cytotoxic destruc-
tion of pancreatic beta cells. Nevertheless, 
our findings support that Kv1.3 channels 
have an important role in each investigated 
lymphocyte subset in T1DM, including Th2 
lymphocytes acting as counterbalancing fac-
tors in the development of T1DM through 
the production of anti-inflammatory 
cytokines (12). Therefore,  administration 
measured samples of healthy individuals 
and MS patients with no immunomodula-
tory therapy, as well as MS patients treated 
with interferon beta (IFN-b), currently 
regarded as the most effective therapy of 
MS. We discovered increased sensitivity of 
CD8 cells to Kv1.3 channel inhibition in 
MS. Therefore, from the CD4-CD8 point 
of view, we demonstrated specific immu-
nomodulation that may be beneficial in the 
therapy of MS via the selective suppression 
of CD8 cytotoxic lymphocytes over CD4 
helper cells. However, this specificity is not 
present within the CD4 subset, since our 
results suggest that Th1 and Th2 cells are 
similarly suppressed upon the inhibition of 
Kv1.3 channels. Since the cytokine balance 
is of utmost importance in the regulation 
of the autoimmune reaction, the inhibition 
of the Th2 subset would probably result in 
a setback of therapeutic efforts in MS. Our 
findings are relevant in the light of observa-
tions regarding the contribution of TEM 
cells to the development of MS, as described 
above. Although the Kv1.3high IKCa1low 
pattern is found in both CD4+ and CD8+ 
TEM cells, we can assume that the major-
ity of TEM cells are CD8+, since TEM 
cells express immediate effector function. 
This might provide an explanation for the 
increased sensitivity of CD8 cells to Kv1.3 
channel inhibition in MS in our study.
We have also demonstrated important 
differences in calcium influx kinetics and 
lymphocyte potassium channel function in 
MS patients with and without IFN-b ther-
apy. Selective blockers of the Kv1.3 channel 
might be promising drugs in combination 
therapy, supplementing the presently used 
IFN-b treatment. Our results indicate that 
IFN-b therapy is related to compensatory 
changes only in the Th1 subset in MS regard-
ing calcium influx kinetics and the func-
tion of potassium channels. However, the 
increased function of the Th2 subset, and 
therefore the production of anti-inflamma-
tory cytokines are less affected. This might 
contribute to a more effective treatment of 
the autoimmune process in this disorder (9).
rheuMatoiD arthritiS
The short-term activation of periph-
eral blood and synovial fluid T lympho-
cytes, especially that of autoreactive T 
cells plays a crucial role in initiating and 
maintaining the chronic inflammation in 
the joints of patients suffering from RA. 
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